Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INCALXO · Entity 6040 | VP Fin & Chief Acct Officer | July 21, 2020 | July 21, 2020 |
| Enovix CorpENVX · Entity 5188 | Chief Financial Officer | July 06, 2023 | July 07, 2023 |
| PDL BIOPHARMA, INC.PDLI · Entity 143144 | VP, Finance and CAO | December 15, 2017 | December 20, 2017 |
| Tricida, Inc.TCDA · Entity 122050 | VP Fin & Chief Acct Officer | February 24, 2020 | February 26, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALX ONCOLOGY HOLDINGS INC
Report date July 21, 2020 · Filed July 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,000 |
Reported balance
After 2020-07-21 transaction · row 1
1 source rowRow 1 · 2020-07-21 · Purchase · Acquired 3,000 · Balance 3,000 |
Enovix Corp
Report date July 06, 2023 · Filed July 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 621,385 |
Reported balance
After 2023-07-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-07-06 · Tax withholding · Disposed 1,361 · Balance 621,385 F1: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on July 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: Includes 417,792 shares issuable upon the settlement of RSUs granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on July 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: Includes 417,792 shares issuable upon the settlement of RSUs granted to the Reporting Person.
PDL BIOPHARMA, INC.
Report date December 15, 2017 · Filed December 20, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 139,587 |
Reported balance
After 2017-12-15 transaction · row 1
1 source rowRow 1 · 2017-12-15 · Disposition to issuer · Disposed 5,513 · Balance 139,587 F1: Disposition of common stock due to performance criteria not being achieved under equity incentive plans. |
| Common stockSEC Table I · non-derivative | IndirectHeld by Spouse | 20,590 |
Reported balance
Holding disclosure · report date 2017-12-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 20,590 |
Filing footnotes · ownership attribution and instrument terms
F1: Disposition of common stock due to performance criteria not being achieved under equity incentive plans.
Tricida, Inc.
Report date February 24, 2020 · Filed February 26, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.12 · Expires 2030-02-23 | Direct | 60,000 |
Reported balance
After 2020-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-02-24 · Grant · Acquired 60,000 · Balance 60,000 F1: The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 24, 2021, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase. |
Filing footnotes · ownership attribution and instrument terms
F1: The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 24, 2021, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2023 Filed Jul 7, 2023 16:16 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,361 | $18.63 | $25,355.43 |
DisclosureSEC source: 0001828318-23-000146 · wk-form4_1688760996.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 621,385 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on July 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 417,792 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 16:07 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,522 | $13.63 | $20,744.86 |
DisclosureSEC source: 0001828318-23-000132 · wk-form4_1687550820.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,746 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on June 22, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 422,453 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| June 10, 2023 Filed Jun 14, 2023 21:00 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 387 | $13.73 | $5,313.51 |
DisclosureSEC source: 0001828318-23-000108 · wk-form4_1686790821.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624,268 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on June 10, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 428,703 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:33 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 782 | $13.61 | $10,643.02 |
DisclosureSEC source: 0001828318-23-000106 · wk-form4_1686270817.xml · nonDerivative · entry 2 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624,655 F3 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the receipt of a fully vested award of RSUs on June 7, 2023. F2 · balance_after: Includes 430,290 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:33 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 3,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001828318-23-000106 · wk-form4_1686270817.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,437 F1 · shares: Reflects shares of the Issuer's common stock issued to the Reporting Person upon the receipt of a fully vested award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer's common stock. F2 · balance_after: Includes 430,290 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 16:15 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 5,297 | $13.72 | $72,674.84 |
DisclosureSEC source: 0001828318-23-000100 · wk-form4_1686168929.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,227 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on June 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 430,290 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| May 22, 2023 Filed May 23, 2023 17:11 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,522 | $12.09 | $18,400.98 |
DisclosureSEC source: 0001628280-23-019447 · wk-form4_1684876275.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 627,524 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on May 22, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 452,039 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| May 10, 2023 Filed May 11, 2023 18:38 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 387 | $13.02 | $5,038.74 |
DisclosureSEC source: 0001628280-23-017689 · wf-form4_168384468590843.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 629,046 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on May 10, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 458,289 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| May 06, 2023 Filed May 9, 2023 20:29 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 757 | $12.64 | $9,568.48 |
DisclosureSEC source: 0001628280-23-016997 · wf-form4_168367854655898.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 629,433 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on May 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 459,875 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| April 22, 2023 Filed Apr 25, 2023 16:15 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,522 | $12.59 | $19,161.98 |
DisclosureSEC source: 0001628280-23-012936 · wf-form4_168245371310448.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,190 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on April 22, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 1,614 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 6, 2022. F3 · balance_after: Includes 477,428 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 17:48 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 76,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-011432 · wf-form4_168133606545499.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,098 F1 · shares: Reflects shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in a series of forty-eight (48) successive equal monthly installments measured from April 10, 2023, the vesting commencement date, subject to the Reporting Person's continuous service through such applicable vesting date. F2 · balance_after: Includes 483,678 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 17:03 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 757 | $12.31 | $9,318.67 |
DisclosureSEC source: 0001628280-23-011122 · wf-form4_168090140140727.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 553,937 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on April 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 407,517 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 20:06 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,522 | $11.01 | $16,757.22 |
DisclosureSEC source: 0001828318-23-000089 · wf-form4_167961637962949.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554,694 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on March 22, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 410,624 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 17:13 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 757 | $9.87 | $7,471.59 |
DisclosureSEC source: 0001828318-23-000073 · wf-form4_167822720600999.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,216 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on March 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 416,874 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| February 22, 2023 Filed Feb 22, 2023 21:03 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,522 | $8.28 | $12,602.16 |
DisclosureSEC source: 0001828318-23-000067 · wf-form4_167711779058364.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,973 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on February 22, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 419,981 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:37 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 28,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001828318-23-000048 · wf-form4_167660142626838.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,332 F1 · shares: Reflects shares issuable upon the settlement of performance restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 50% of the PRSUs were fully vested on February 14, 2023 and 50% of the RSUs will vest on February 14, 2024, subject to the Reporting Person's continuous service through such applicable vesting date. F2 · balance_after: Includes 426,231 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| February 14, 2023 Filed Feb 22, 2023 21:00 UTC Amendment | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 3,837 | $8.45 | $32,422.65 |
DisclosureSEC source: 0001828318-23-000063 · wf-form4a_167711762847088.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,495 F1 · kind: On February 16, 2023, the Reporting Person filed a Form 4 which inadvertently neglected to report the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of 14,446 performance restricted stock units ("RSUs") on February 14, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 426,231 shares issuable upon the settlement of RSUs granted to the Reporting Person. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 19:49 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 922 | $8.97 | $8,270.34 |
DisclosureSEC source: 0001828318-23-000037 · wf-form4_167581734132028.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,440 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on February 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 411,785 shares issuable on the settlement of RSUs granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 22, 2023 Filed Jan 23, 2023 20:02 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,854 | $7.96 | $14,757.84 |
DisclosureSEC source: 0001828318-23-000022 · wf-form4_167452214409712.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,362 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on January 22, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 414,893 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 18:27 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 922 | $8.05 | $7,422.10 |
DisclosureSEC source: 0001828318-23-000005 · wf-form4_167339324093155.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,216 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on January 6, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 421,143 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| December 22, 2022 Filed Dec 23, 2022 16:19 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 2,460 | $10.80 | $26,568.00 |
DisclosureSEC source: 0001828318-22-000094 · wf-form4_167183033939320.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,138 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on December 22, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 424,250 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| December 06, 2022 Filed Dec 8, 2022 18:26 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 1,223 | $11.73 | $14,345.79 |
DisclosureSEC source: 0001828318-22-000090 · wf-form4_167054196467845.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,598 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on December 6, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 430,500 shares issuable on the settlement of RSUs granted to the Reporting Person. F3 · balance_after: Includes one share acquired under the Issuer's 2021 Employee Stock Purchase Plan on November 8, 2022. Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 19:00 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 29,584 | $12.45 | $368,320.80 |
DisclosureSEC source: 0001828318-22-000086 · wf-form4_166942080544145.xml · nonDerivative · entry 2 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,820 F2 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of RSUs on November 22, 2022. F3 · balance_after: Includes 433,607 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 19:00 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001828318-22-000086 · wf-form4_166942080544145.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,404 F1 · shares: Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs vested on November 22, 2022 (the "Vesting Commencement Date"); and the remainder will vest in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| November 06, 2022 Filed Nov 8, 2022 19:29 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 757 | $10.74 | $8,130.18 |
DisclosureSEC source: 0001828318-22-000078 · wf-form4_166795376338344.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,404 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on November 6, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 133,607 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 20:07 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 757 | $19.68 | $14,897.76 |
DisclosureSEC source: 0001828318-22-000053 · wf-form4_166553325305725.xml · nonDerivative · entry 3 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,161 F3 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of RSUs on October 6, 2022. F4 · balance_after: Includes 136,714 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| September 06, 2022 Filed Oct 11, 2022 20:07 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 757 | $18.96 | $14,352.72 |
DisclosureSEC source: 0001828318-22-000053 · wf-form4_166553325305725.xml · nonDerivative · entry 2 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,918 F2 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of RSUs on September 6, 2022. Read SEC document |
| August 06, 2022 Filed Oct 11, 2022 20:07 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 757 | $14.41 | $10,908.37 |
DisclosureSEC source: 0001828318-22-000053 · wf-form4_166553325305725.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,675 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on August 6, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 16:52 UTC | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 741 | $8.68 | $6,431.88 |
DisclosureSEC source: 0001209191-22-041672 · doc4.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,432 F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on July 6, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 146,035 shares issuable on the settlement of RSUs granted to the Reporting Person. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:16 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 74,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035253 · doc4.xml · nonDerivative · entry 2 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,173 F2 · shares: Reflects shares issuable on the settlement of RSUs granted to the Reporting Person. 1/24th of the RSUs will vest in twenty-four (24) successive equal monthly installments measured from the Vesting Commencement Date, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:16 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 74,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035253 · doc4.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,602 F1 · shares: Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on the first anniversary of the date of grant (the "Vesting Commencement Date"); and the remainder will vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| May 20, 2022 Filed May 24, 2022 19:30 UTC | Enovix Corp ENVX · Entity 5188 | GrantCommon Stock | 2,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031746 · doc4.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,725 F1 · shares: The Reporting Person received a fully vested award of 2,725 restricted stock units on May 20, 2022. Each restricted stock unit represents a right to receive one share of the Issuer's common stock. Read SEC document |
| May 20, 2022 Filed Jun 8, 2022 20:10 UTC Amendment | Enovix Corp ENVX · Entity 5188 | Tax withholdingCommon Stock | 694 | $9.31 | $6,461.14 |
DisclosureSEC source: 0001209191-22-035248 · doc4a.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,031 F1 · kind: On May 24,2022, the Reporting Person filed a Form 4 which inadvertently neglected to report the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the fully vested award of 2,725 restricted stock units on May 20, 2022. Each restricted stock unit represented the right to received one share of the Issuer's common stock. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 17:17 UTC | Enovix Corp ENVX · Entity 5188 | GrantStock Option (Right to Buy) · Derivative | 4,242 | $0.00 Strike: $15.47 | $0.00 |
DisclosureSEC source: 0001209191-22-020571 · doc4.xml · derivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,242 Underlying: Common Stock · 4,242 shares Expires 2032-03-17 F1 · derivative.exercise_date: The shares subject to the option are fully vested on the date of grant. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 16:38 UTC | Enovix Corp ENVX · Entity 5188 | OtherWarrant (Right to Purchase) · Derivative | 1,000 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001209191-21-069969 · doc4.xml · derivative · entry 2 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2026-07-14 F1 · derivative.exercise_date: Warrants become exercisable on the later of (i) 30 days after the completion of Issuer's initial business combination, which was on July 14, 2021, and (ii) 12 months from the closing of the Rodgers Silicon Valley Acquisition Corporation initial public offering, which was on December 4, 2020, and they expire five years after the completion of Issuer's initial business combination or earlier upon redemption or liquidation. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 16:38 UTC | Enovix Corp ENVX · Entity 5188 | OtherCommon Stock | 1,000 | $11.50 | $11,500.00 |
DisclosureSEC source: 0001209191-21-069969 · doc4.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Read SEC document |
| August 12, 2021 Filed Aug 12, 2021 16:06 UTC | Enovix Corp ENVX · Entity 5188 | PurchaseCommon Stock | 20,000 | $14.75 | $295,000.00 |
DisclosureSEC source: 0001209191-21-051079 · doc4.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Read SEC document |
| July 14, 2021 Filed Jul 16, 2021 20:56 UTC | Enovix Corp ENVX · Entity 5188 | GrantStock Option (Right to Buy) · Derivative | 369,226 | Not disclosed Strike: $9.26 | Not disclosed |
DisclosureSEC source: 0001209191-21-047043 · doc4.xml · derivative · entry 3 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,226 Underlying: Common Stock · 369,226 shares Expires 2031-04-19 F1 · kind: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. F7 · price: Received in exchange for a stock option to purchase 2,000,000 shares of Legacy Enovix Common Stock. F6 · derivative.exercise_date: The shares subject to the option are immediately exercisable. 1/4th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 1, 2021, and 1/48th of the shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. Read SEC document |
| July 14, 2021 Filed Jul 16, 2021 20:56 UTC | Enovix Corp ENVX · Entity 5188 | GrantStock Option (Right to Buy) · Derivative | 71,020 | Not disclosed Strike: $9.26 | Not disclosed |
DisclosureSEC source: 0001209191-21-047043 · doc4.xml · derivative · entry 2 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,020 Underlying: Common Stock · 71,020 shares Expires 2031-04-19 F1 · kind: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. F5 · price: Received in exchange for a stock option to purchase 384,700 shares of Legacy Enovix Common Stock. F4 · derivative.exercise_date: The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date. Read SEC document |
| July 14, 2021 Filed Jul 16, 2021 20:56 UTC | Enovix Corp ENVX · Entity 5188 | GrantStock Option (Right to Buy) · Derivative | 276,918 | Not disclosed Strike: $9.26 | Not disclosed |
DisclosureSEC source: 0001209191-21-047043 · doc4.xml · derivative · entry 1 Pietzke Steffen · CIK 0001647008 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,918 Underlying: Common Stock · 276,918 shares Expires 2031-04-19 F1 · kind: Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. F3 · price: Received in exchange for a stock option to purchase 1,500,000 shares of Legacy Enovix Common Stock. F2 · derivative.exercise_date: The shares subject to the option are immediately exercisable. 1/5th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 18, 2021, and 1/60th of the shares subject to the option will vest in 48 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. Read SEC document |
| July 21, 2020 Filed Jul 21, 2020 23:59 UTC | ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 | PurchaseCommon Stock | 3,000 | $19.00 | $57,000.00 |
DisclosureSEC source: 0000899243-20-019910 · doc4.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · VP Fin & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 23:03 UTC | ALX ONCOLOGY HOLDINGS INC ALXO · Entity 6040 | GrantEmployee Stock Option (right to buy) · Derivative | 41,789 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019576 · doc4.xml · derivative · entry 1 Pietzke Steffen · CIK 0001647008 · VP Fin & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,789 Underlying: Common Stock · 41,789 shares Expires 2030-07-16 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 16, 2020. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 19:20 UTC | Tricida, Inc. TCDA · Entity 122050 | GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $35.12 | $0.00 |
DisclosureSEC source: 0001595585-20-000019 · wf-form4_158276283085738.xml · derivative · entry 1 Pietzke Steffen · CIK 0001647008 · VP Fin & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-02-23 F1 · derivative.exercise_date: The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 24, 2021, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase. Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 18:54 UTC | Tricida, Inc. TCDA · Entity 122050 | GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $34.27 | $0.00 |
DisclosureSEC source: 0001595585-19-000184 · wf-form4_156660083561508.xml · derivative · entry 1 Pietzke Steffen · CIK 0001647008 · VP Fin & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-08-22 F1 · derivative.exercise_date: The option to purchase common stock will vest in eighteen equal monthly installments from August 22, 2019 to February 22, 2021, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 16:18 UTC | Tricida, Inc. TCDA · Entity 122050 | GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $22.82 | $0.00 |
DisclosureSEC source: 0001595585-19-000034 · wf-form4_155087030578317.xml · derivative · entry 1 Pietzke Steffen · CIK 0001647008 · VP Fin & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-02-20 F1 · derivative.exercise_date: The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 20, 2020, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase. Read SEC document |
| July 02, 2018 Filed Jul 2, 2018 20:58 UTC | Tricida, Inc. TCDA · Entity 122050 | PurchaseCommon Stock | 10,527 | $19.00 | $200,013.00 |
DisclosureSEC source: 0001140361-18-031049 · form4.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · VP Fin & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,527 Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 01:03 UTC | PDL BIOPHARMA, INC. PDLI · Entity 143144 | Disposition to issuerCommon stock | 5,513 | $0.00 | $0.00 |
DisclosureSEC source: 0000882104-17-000125 · wf-form4_151373181920174.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,587 F1 · shares: Disposition of common stock due to performance criteria not being achieved under equity incentive plans. Read SEC document |
| March 04, 2017 Filed Mar 8, 2017 01:18 UTC | PDL BIOPHARMA, INC. PDLI · Entity 143144 | GrantCommon stock | 98,039 | $2.04 | $199,999.56 |
DisclosureSEC source: 0000882104-17-000021 · wf-form4_148893591103172.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,100 F1 · shares: The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2018; 16.66% on December 2019; 16.66% on December 2020; and 16.66% on December 2021. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 21:16 UTC | PDL BIOPHARMA, INC. PDLI · Entity 143144 | Disposition to issuerCommon stock | 663 | $0.00 | $0.00 |
DisclosureSEC source: 0000882104-16-000248 · wf-form4_148183655795084.xml · nonDerivative · entry 1 Pietzke Steffen · CIK 0001647008 · Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,061 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.